
Omada Health (OMDA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0.10 | $0.08 | 25.0 % |
| Q2 | Aug 6, 2026 | $0.08 | $0.06 | 33.3 % |
| Q1 | May 7, 2026 | $-0.05 | $-0.05 | 0.00 % |
| Q4 | Mar 5, 2026 | $0.08 | $-0.07 | 214.3 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $91.00M | $85.66M | 6.23 % |
| Q2 | Aug 6, 2026 | $87.84M | $80.40M | 9.25 % |
| Q1 | May 7, 2026 | $78.05M | $74.23M | 5.14 % |
| Q4 | Mar 5, 2026 | $75.85M | $69.69M | 8.83 % |
Omada Health (OMDA) publicó su última previsión de noviembre 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $344M - $346M para el período.
En comparación con la previsión anterior, Omada Health elevado redujo su previsión de ingresos desde un rango anterior de $334M - $340M.
Omada Health ha emitido 8 actualizaciones de orientación entre el agosto 7, 2025 y el noviembre 5, 2026. During this period, the company raised its outlook 6 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.08 | $0.06 | $-0.05 | $-0.07 |
| Actual | $0.10 | $0.08 | $-0.05 | $0.08 |
| Surprise | +25.0% | +33.3% | 0.00% | +214.3% |
| Revenue | ||||
| Estimate | $85.7M | $80.4M | $74.2M | $69.7M |
| Actual | $91.0M | $87.8M | $78.0M | $75.8M |
| Surprise | +6.23% | +9.25% | +5.14% | +8.83% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.11 | $0.05 | $0.07 | $0.08 |
| Revenue | ||||
| Consensus | $87.7M | $94.8M | — | — |